Remote Collaboration and Evidence-Based Care
Hello to all of you. My name is John, and I will speak today on the value of working together remotely and providing evidence-based treatments for people living in distant locations. Patients who are difficult to reach or live far from their doctors need superior medical care delivered via distance communication and evidence-based therapy.
NURS FPX 4030 Assessment 4: Team members can reach a consensus on treatment strategies and provide individuals and their households with the knowledge and resources required to achieve the most significant outcomes by employing virtual collaboration (Haimi, 2023).
Evidence-Based Care Plan
Caitlynn, age 2, has been diagnosed with a condition called cystic fibrosis. Her treatment group consists of Dr. Copeland, her physician; Virginia Anderson; Rebecca Helgo; clinical social assistant Marta Simmons; and outreach social therapist Madeline Becker.
Given that Caitlynn has recently undergone a hospital stay for pneumonia and that she resides over an hour away from the institution, managing her ongoing care will be difficult (Vila Health, 2023). To optimize Caitlynn’s security and outcomes, the care provider should place a high priority on diligently following Caitlynn’s cystic fibrosis diagnosis and therapy recommendations, keeping a close eye out for any issues, and providing her relatives with comprehensive guidance and assistance.
The Cystic Fibrosis Foundation recommends that Caitlynn receive treatment with lipid-soluble nutrients, digestive enzyme nutrients, drumming and exercise for breathing, and medicines such as dornase alfa to enhance her pulmonary function (Mariotti Zani et al., 2023). Through telemedicine, a breathing specialist could offer initial instruction and further investigation to ensure optimum practice in clearing the airways. Caitlynn’s parents must maintain an eye out for signs of intestinal obstruction, breathing problems, and other common cystic fibrosis side effects, and they should have convenient accessibility to three medical specialists (Frantzen et al., 2023). Lastly, the care team has to make sure Caitlynn’s family has access to economic, community, and mental resources as they cope with her condition.
This entails figuring out insurance plans, using online resources, locating neighborhood assistance programs, and constantly communicating with Caitlynn’s medical providers (VilaHealth, 2023). If Caitlynn receives strict therapy, close supervision, and support from her family on all sides, she is more likely to experience excellent health results and an improved quality of life.
NURS FPX 4030 Assessment 4: Need for Further Information
Given more details about Caitlynn’s tests for lung function and specific CFTR gene changes, her medical team might more accurately customize her treatment strategy. Understanding the details of her cystic fibrosis diagnosis may help predict the way it will progress and identify the most effective therapies for the child (Patel et al., 2022). The outcomes of the pulmonary function exams would provide a reference point for comparing the advancement or decline in her breathing ability in years to come. Using that data, a respiratory professional may determine the ideal amount and length for Caitlynn’s airway-clearing treatments.
If the staff had additional information regarding her parents’ work schedules, accessibility to conveyance, and level of technical convenience, they would be more qualified to choose the mediums and timeframe for virtual care and ongoing education. (Shah et al., 2022). A more targeted, customized approach for Caitlynn would be made possible by early medical facilities’ interpersonal and administrative data gathering.
Evidence-Based Practice Model
The Stetler model provides the structure for integrating research findings and data into the clinical setting, which strongly focuses on thinking critically and using private organization data. Caitlynn’s treatment plan was developed using the Stetler approach, which includes five stages that follow:
To prepare Caitlynn for evidence-based therapy, her medical group first concentrated on curing her pneumonia, improving her respiratory health, and preventing further complications. Next, using resources, including medical recommendations and scientific journals, the team searched for and evaluated external studies on cystic fibrosis treatment therapy (Somayaji et al., 2020). The relevant studies on medications, vitamin supplements for cleaning the respiratory tract, and other subjects were gathered.
The group then considered Caitlynn’s unique circumstances, including her remote residence, family dynamics, and the available resources nearby, as they examined the information in question. They concluded that Caitlynn might plausibly have the outside evidence used in her argument if her social circumstances were slightly altered. The research data was interpreted into a whole therapy regimen for Caitlynn during the fourth phase, which included further investigation and synchronized education strategies, medications, treatments, and monitoring protocols (Kavalieratos et al., 2020).
Lastly, the entire group will evaluate the outcomes by monitoring Caitlynn’s development in dietary habits, her way of life, and lung function. Her response will guide any alterations to the plan. The Stetler approach simplifies identifying the best evidence, deciding how to apply it to Caitlynn, and turning it into a comprehensive, customized therapy program (Schallmoser et al., 2023).
Evaluation of Positive Results
Her medical team may track Caitlynn’s wellness via regular assessments between clinic appointments and online medical care sessions. Monitoring emergency room trips and hospital stays due to bowel blockages or respiratory infections, tracking variations in the size and weight of her ranges, and keeping an eye on her lung function via pulmonary function testing are all measurable outcomes.
Surveys and conversations can also be employed during subsequent appointments to assess patient feedback, including compliance with medications, parental trust in providing treatment, Caitlynn’s positive outlook on existence, and handling her CF complaints. By integrating objective clinical data with emotional quality-of-life input from Caitlynn and her companions, the medical professionals will be able to evaluate the positive impacts of the evidence-based medication regimen on Caitlynn’s achievements (Quittner et al., 2020).
Evidence Relation to Decision-Making
The Cystic Fibrosis Foundation’s therapeutic recommendations provided precious study data for Caitlynn’s therapy. As the leading authority on treating cystic fibrosis, their comprehensive suggestions outlined the minimum needed to improve nutrition, prevent complications, manage respiratory problems, and organize multidisciplinary care.
Specifically, they provided guidance on best practices for managing Caitlynn’s disease, including clearing her breathing passages using inhaled medications like dornase alfa, supplementing fat-soluble vitamins, and determining the appropriate dosage of enzymes from the pancreas (Nowak et al., 2021). Their guidance for tracking the condition of
The lungs, seeking for issues, and treating cystic fibrosis effectively drove the medical group’s aims for Caitlynn. Furthermore, the primary doctors responsible for Caitlynn’s experience offered vital background information for implementing the suggestions. Because the medical professionals had direct experience with Caitlynn and her companions, the strategies for schooling, subsequent follow-up, and telehealth were tailored to fit their requirements and abilities (VilaHealth, 2023). The welfare counselors’ familiarity with neighborhood resources allowed the family to get emotional, social, and financial support. Combating factual information from national standards with regionally pertinent information from Caitlynn’s medical permitted the team to create a combined, personalized care plan tailored to her requirements. When complementary forms of information are used, recommendations are backed by investigation and consider the patient’s unique needs and environment (Nowak et al., 2022).
NURS FPX 4030 Assessment 4: Relevance Criteria
The CRAAP test provides basic guidelines for evaluating sources based on their credibility, relevance, accuracy, and purpose. The guidelines for cystic fibrosis were updated and published in 2022. They were relevant to the medical requirements and assessment of Caitlynn.
The organization uses information and statistics from the world’s foremost authority on cystic fibrosis. Thus, the suggestions it makes are very credible. Their approach to medical review ensures accuracy. Finally, the foundation’s advice’s credibility is reinforced by its nonprofit goal to improve lives via cystic fibrosis studies and therapies. Caitlynn’s evidence-based approach was successfully led by the standards, as shown by the CRAAP standards (Patel et al., 2022).
Benefits of Interdisciplinary Collaboration
Multidisciplinary collaboration yields a holistic approach to addressing Caitlynn’s complicated care needs. The team may consult with other professions, including social services, therapy for breathing, healthcare, and pediatrics, to ensure that the healthcare, passionate, instructive, and integration of medical requirements are met. This comprehensive approach raises the caliber and efficacy of the treatment plan. Collaborating effectively allows team members to gain valuable knowledge and expertise from another person (Lakinet al., 2021).
Challenges of Remote Interdisciplinary Collaboration
Caitlynn’s remote medical team members might need to communicate better while they are apart. When practitioners are dispersed, it may not be easy to schedule regular discussions about cases and discussions across specialties. Communication may also break down in the absence of frequent face-to-face interactions. The medical staff must also navigate several procedures, record-keeping frameworks, and legal requirements to oversee Caitlynn’s treatment across healthcare facilities, centers, and individual practice environments (Tehrani et al., 2020).
Strategies to Mitigate Challenges
One method to enhance collaboration within Caitlynn’s remote healthcare team is to schedule regular online discussions where specialists can discuss and decide on goals while reviewing Caitlynn’s status. A shared infrastructure, such as an encrypted patient portal, should be utilized so those working remotely can access treatment plans, learning resources, and progress reports across locations.
If a coordinator of care is assigned, the medical clinic and any additional involved providers may follow up and connect more rapidly. To facilitate smooth collaboration, team members should create accessible paths for prompt phone calls, text messages, and email discussions. Clear protocols must also be established for Caitlynn’s treatment when she travels between the pediatric clinic, the medical center, professionals, and additional facilities (Li et al., 2021).
Suppose a group of professionals is committed to ongoing interaction, shared records, and a well-coordinated approach. In that case, they may collaborate to improve patient satisfaction regardless of location. Maintaining a family-centered perspective and active participation fosters team unity. NURS FPX 4030 Assessment 4: By establishing regular online interactions, centralized documents, an appointed care coordinator, accessible consulting pathways, and changeover protocols, the dispersed medical team may overcome problems brought on by location. Higher-quality, comprehensive care will benefit individuals like Caitlynn due to their shared perspective and collaboration (Vindrola-Padros et al., 2022).
Role of Interdisciplinary Collaboration
This illustration shows how to improve interdisciplinary collaboration and coordination to treat complicated patients, especially those in distant locations. Instead of only providing reactive consultation when issues arise, the team should focus on proactive and ongoing collaboration in future health situations. Frequent consultations about cases would encourage more comprehensive, integrated approaches to therapy for individuals at increased risk (Schallmoser et al., 2023). By establishing formal procedures for interactions and treatment transitions across organizations, transfers of care may be made more accessible. Creating alliances among healthcare providers and healthcare providers may enhance patient information and regional cooperation. Collaboration technology and attitude may enable isolated staff to go from solo consults to collaborative care. Sensitive patients will get more secure, better care, and tremendous success with this degree of collaboration (Davies et al., 2019).
Conclusion
Caitlynn emphasizes the need for multidisciplinary collaboration and scientifically supported treatment to conquer challenges while providing complicated patient care. Care in remote locations. NURS FPX 4030 Assessment 4: Caitlynn’s plan was meticulously crafted, following localized coordinated care guidelines and professional recommendations. Continual evaluation and adjustment based on Caitlynn’s response to the therapies will be the most significant Outcomes.
Read more about our sample NURS FPX 4030 Assessment 3 PICO (T) Questions and an Evidence-Based Approach for complete information about this class.
References:
Frantzen, T., Barsky, S., LaVecchia, G., Marowitz, M., & Wang, J. (2023). Evolving
nutritional needs in cystic fibrosis. Life (Basel, Switzerland), 13(7), 1431.
https://doi.org/10.3390/life13071431
Haimi, M. (2023). The tragic paradoxical effect of telemedicine on healthcare disparities- a
time for redemption: A narrative review. BMC Medical Informatics and Decision
Making, 23(1), 95. https://doi.org/10.1186/s12911-023-02194-4
Kavalieratos, D., Georgiopoulos, A. M., Dhingra, L., Basile, M. J., Rabinowitz, E.,
Hempstead, S. E., Faro, A., Dellon, E. P., Chen, E., Garlow, G. M., Goggin, J., Goss,
C. H., Hovater, C., Markovitz, M., McAndrews, K. K., McCoy, H., McKinzie, C. J.,
Moreines, L., Lambert, T., & Wendell Reese, R. (2020). Models of palliative care
delivery for individuals with cystic fibrosis: Cystic fibrosis foundation evidenceinformed consensus guidelines. Journal of Palliative Medicine.
https://doi.org/10.1089/jpm.2020.0311
Lakin, L., Davis, B. E., Binns, C. C., Currie, K. M., & Rensel, M. R. (2021). Comprehensive
approach to management of multiple sclerosis: Addressing invisible symptoms—A
narrative review. Neurology and Therapy, 10(1), 75–98.
https://doi.org/10.1007/s40120-021-00239-2
Li, W., Gillies, R., He, M., Wu, C., Liu, S., Gong, Z., & Sun, H. (2021). Barriers and
facilitators to online medical and nursing education during the COVID-19 pandemic:
Perspectives from international students from low- and middle-income countries and
their teaching staff. Human Resources for Health, 19(1).
https://doi.org/10.1186/s12960-021-00609-9
Mariotti Zani, E., Grandinetti, R., Cunico, D., Torelli, L., Fainardi, V., Pisi, G., & Esposito,
S. (2023). Nutritional care in children with cystic fibrosis. Nutrients, 15(3), 479.
https://doi.org/10.3390/nu15030479
Nowak, J. K., Krzyżanowska-Jankowska, P., Drzymała-Czyż, S., Goździk-Spychalska, J.,
Wojsyk-Banaszak, I., Skorupa, W., Sapiejka, E., Miśkiewicz-Chotnicka, A., Brylak,
J., Zielińska-Psuja, B., Lisowska, A., & Walkowiak, J. (2022). Fat-soluble vitamins in
standard vs. liposomal form enriched with vitamin k2 in cystic fibrosis: A randomized
multi-center trial. Journal of Clinical Medicine, 11(2), 462.
https://doi.org/10.3390/jcm11020462
Nowak, J. K., Sobkowiak, P., Drzymała-Czyż, S., Krzyżanowska-Jankowska, P., Sapiejka,
E., Skorupa, W., Pogorzelski, A., Nowicka, A., Wojsyk-Banaszak, I., Kurek, S.,
Zielińska-Psuja, B., Lisowska, A., & Walkowiak, J. (2021). Fat-soluble vitamin
supplementation using liposomes, cyclodextrins, or medium-chain triglycerides in
cystic fibrosis: A randomized controlled trial. Nutrients, 13(12), 4554.
https://doi.org/10.3390/nu13124554
Patel, D., Shan, A., Mathews, S., & Sathe, M. (2022). Understanding cystic fibrosis
comorbidities and their impact on nutritional management. Nutrients, 14(5), 1028.
https://doi.org/10.3390/nu14051028
Quittner, A. L., Abbott, J., Hussain, S., Ong, T., Uluer, A., Hempstead, S., Lomas, P., &
Smith, B. (2020). Integration of mental health screening and treatment into cystic
fibrosis clinics: Evaluation of initial implementation in 84 programs across the United
States. Pediatric Pulmonology, 55(11), 2995–3004.
https://doi.org/10.1002/ppul.24949
Schallmoser, S., Zueger, T., Kraus, M., Saar-Tsechansky, M., Stettler, C., & Feuerriegel, S.
(2023). Machine learning for predicting micro- and macrovascular complications in
individuals with prediabetes or diabetes: Retrospective cohort study. Journal of
Medical Internet Research, 25(1). https://doi.org/10.2196/42181
Shah, S. R., Hassan, Z., Waqas, S., Ali, A. A., & Hamza, M. M. (2022). Comparison of
postural drainage and percussion techniques in cystic fibrosis patients. Pakistan
Journal of Medical and Health Sciences, 16(2), 201–203.
https://doi.org/10.53350/pjmhs22162201
Somayaji, R., Nichols, D. P., & Bell, S. C. (2020). Cystic fibrosis – Ten promising
therapeutic approaches in the current era of care. Expert Opinion on Investigational
Drugs, 29(10), 1107–1124. https://doi.org/10.1080/13543784.2020.1805733
Tehrani, B. N., Truesdell, A. G., Psotka, M. A., Rosner, C., Singh, R., Sinha, S. S., Damluji,
A. A., & Batchelor, W. B. (2020). A standardized and comprehensive approach to the
management of cardiogenic shock. JACC: Heart Failure, 8(11), 879–891.
https://doi.org/10.1016/j.jchf.2020.09.005
Vindrola-Padros, C., Ramsay, A. I. G., Black, G., Barod, R., Hines, J., Mughal, M., Shackley,
D., & Fulop, N. J. (2022). Inter-organisational collaboration enabling care delivery in
a specialist cancer surgery provider network: A qualitative study. Journal of Health
Services Research & Policy. https://doi.org/10.1177/13558196211053954
